Cargando…
Ferumoxytol-enhanced magnetic resonance imaging in acute myocarditis
OBJECTIVES: Ultrasmall superparamagnetic particles of iron oxide (USPIO)-enhanced MRI can detect tissue-resident macrophage activity and identify cellular inflammation within tissues. We hypothesised that USPIO-enhanced MRI would provide a non-invasive imaging technique that would improve the diagno...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861394/ https://www.ncbi.nlm.nih.gov/pubmed/28986407 http://dx.doi.org/10.1136/heartjnl-2017-311688 |
_version_ | 1783308083983810560 |
---|---|
author | Stirrat, Colin G Alam, Shirjel R MacGillivray, Thomas J Gray, Calum D Dweck, Marc R Dibb, Kevin Spath, Nick Payne, John R Prasad, Sanjay K Gardner, Roy S Mirsadraee, Saeed Henriksen, Peter A Semple, Scott IK Newby, David E |
author_facet | Stirrat, Colin G Alam, Shirjel R MacGillivray, Thomas J Gray, Calum D Dweck, Marc R Dibb, Kevin Spath, Nick Payne, John R Prasad, Sanjay K Gardner, Roy S Mirsadraee, Saeed Henriksen, Peter A Semple, Scott IK Newby, David E |
author_sort | Stirrat, Colin G |
collection | PubMed |
description | OBJECTIVES: Ultrasmall superparamagnetic particles of iron oxide (USPIO)-enhanced MRI can detect tissue-resident macrophage activity and identify cellular inflammation within tissues. We hypothesised that USPIO-enhanced MRI would provide a non-invasive imaging technique that would improve the diagnosis and management of patients with acute myocarditis. METHODS: Ten volunteers and 14 patients with suspected acute myocarditis underwent T2, T2* and late gadolinium enhancement (LGE) 3T MRI, with further T2* imaging at 24 hours after USPIO (ferumoxytol, 4 mg/kg) infusion, at baseline and 3 months. Myocardial oedema and USPIO enhancement were determined within areas of LGE as well as throughout the myocardium. RESULTS: Myocarditis was confirmed in nine of the 14 suspected cases of myocarditis. There was greater myocardial oedema in regions of LGE in patients with myocarditis when compared with healthy volunteer myocardium (T2 value, 57.1±5.3 vs 46.7±1.6 ms, p<0.0001). There was no demonstrable difference in USPIO enhancement between patients and volunteers even within regions displaying LGE (change in R2*, 35.0±15.0 vs 37.2±9.6 s(−1), p>0.05). Imaging after 3 months in patients with myocarditis revealed a reduction in volume of LGE, a reduction in oedema measures within regions displaying LGE and improvement in ejection fraction (mean −19.7 mL, 95% CI (−0.5 to −40.0)), −5.8 ms (−0.9 to −10.7) and +6% (0.5% to 11.5%), respectively, p<0.05 for all). CONCLUSION: In patients with acute myocarditis, USPIO-enhanced MRI does not provide additional clinically relevant information to LGE and T2 mapping MRI. This suggests that tissue-resident macrophages do not provide a substantial contribution to the myocardial inflammation in this condition. Clinical trial registration NCT02319278; Results. |
format | Online Article Text |
id | pubmed-5861394 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-58613942018-03-22 Ferumoxytol-enhanced magnetic resonance imaging in acute myocarditis Stirrat, Colin G Alam, Shirjel R MacGillivray, Thomas J Gray, Calum D Dweck, Marc R Dibb, Kevin Spath, Nick Payne, John R Prasad, Sanjay K Gardner, Roy S Mirsadraee, Saeed Henriksen, Peter A Semple, Scott IK Newby, David E Heart Heart Failure and Cardiomyopathies OBJECTIVES: Ultrasmall superparamagnetic particles of iron oxide (USPIO)-enhanced MRI can detect tissue-resident macrophage activity and identify cellular inflammation within tissues. We hypothesised that USPIO-enhanced MRI would provide a non-invasive imaging technique that would improve the diagnosis and management of patients with acute myocarditis. METHODS: Ten volunteers and 14 patients with suspected acute myocarditis underwent T2, T2* and late gadolinium enhancement (LGE) 3T MRI, with further T2* imaging at 24 hours after USPIO (ferumoxytol, 4 mg/kg) infusion, at baseline and 3 months. Myocardial oedema and USPIO enhancement were determined within areas of LGE as well as throughout the myocardium. RESULTS: Myocarditis was confirmed in nine of the 14 suspected cases of myocarditis. There was greater myocardial oedema in regions of LGE in patients with myocarditis when compared with healthy volunteer myocardium (T2 value, 57.1±5.3 vs 46.7±1.6 ms, p<0.0001). There was no demonstrable difference in USPIO enhancement between patients and volunteers even within regions displaying LGE (change in R2*, 35.0±15.0 vs 37.2±9.6 s(−1), p>0.05). Imaging after 3 months in patients with myocarditis revealed a reduction in volume of LGE, a reduction in oedema measures within regions displaying LGE and improvement in ejection fraction (mean −19.7 mL, 95% CI (−0.5 to −40.0)), −5.8 ms (−0.9 to −10.7) and +6% (0.5% to 11.5%), respectively, p<0.05 for all). CONCLUSION: In patients with acute myocarditis, USPIO-enhanced MRI does not provide additional clinically relevant information to LGE and T2 mapping MRI. This suggests that tissue-resident macrophages do not provide a substantial contribution to the myocardial inflammation in this condition. Clinical trial registration NCT02319278; Results. BMJ Publishing Group 2018-02 2017-10-06 /pmc/articles/PMC5861394/ /pubmed/28986407 http://dx.doi.org/10.1136/heartjnl-2017-311688 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Heart Failure and Cardiomyopathies Stirrat, Colin G Alam, Shirjel R MacGillivray, Thomas J Gray, Calum D Dweck, Marc R Dibb, Kevin Spath, Nick Payne, John R Prasad, Sanjay K Gardner, Roy S Mirsadraee, Saeed Henriksen, Peter A Semple, Scott IK Newby, David E Ferumoxytol-enhanced magnetic resonance imaging in acute myocarditis |
title | Ferumoxytol-enhanced magnetic resonance imaging in acute myocarditis |
title_full | Ferumoxytol-enhanced magnetic resonance imaging in acute myocarditis |
title_fullStr | Ferumoxytol-enhanced magnetic resonance imaging in acute myocarditis |
title_full_unstemmed | Ferumoxytol-enhanced magnetic resonance imaging in acute myocarditis |
title_short | Ferumoxytol-enhanced magnetic resonance imaging in acute myocarditis |
title_sort | ferumoxytol-enhanced magnetic resonance imaging in acute myocarditis |
topic | Heart Failure and Cardiomyopathies |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861394/ https://www.ncbi.nlm.nih.gov/pubmed/28986407 http://dx.doi.org/10.1136/heartjnl-2017-311688 |
work_keys_str_mv | AT stirratcoling ferumoxytolenhancedmagneticresonanceimaginginacutemyocarditis AT alamshirjelr ferumoxytolenhancedmagneticresonanceimaginginacutemyocarditis AT macgillivraythomasj ferumoxytolenhancedmagneticresonanceimaginginacutemyocarditis AT graycalumd ferumoxytolenhancedmagneticresonanceimaginginacutemyocarditis AT dweckmarcr ferumoxytolenhancedmagneticresonanceimaginginacutemyocarditis AT dibbkevin ferumoxytolenhancedmagneticresonanceimaginginacutemyocarditis AT spathnick ferumoxytolenhancedmagneticresonanceimaginginacutemyocarditis AT paynejohnr ferumoxytolenhancedmagneticresonanceimaginginacutemyocarditis AT prasadsanjayk ferumoxytolenhancedmagneticresonanceimaginginacutemyocarditis AT gardnerroys ferumoxytolenhancedmagneticresonanceimaginginacutemyocarditis AT mirsadraeesaeed ferumoxytolenhancedmagneticresonanceimaginginacutemyocarditis AT henriksenpetera ferumoxytolenhancedmagneticresonanceimaginginacutemyocarditis AT semplescottik ferumoxytolenhancedmagneticresonanceimaginginacutemyocarditis AT newbydavide ferumoxytolenhancedmagneticresonanceimaginginacutemyocarditis |